Aberrant induction of p19Arf-mediated cellular senescence contributes to neurodevelopmental defects

Area of Science:

• Developmental biology
• Neuroscience
• Toxicology

Background:

• Valproic acid (VPA) is a common medication for epilepsy, bipolar disorder, and migraines.
• Prenatal VPA exposure is linked to significant birth defects, cognitive impairment, and autism spectrum disorder.
• The precise mechanisms by which VPA induces developmental defects remain largely unknown.

Purpose of the Study:

• To investigate the cellular and molecular mechanisms underlying VPA-induced developmental defects.
• To model key VPA exposure effects, including exencephaly, microcephaly, and spinal defects, using embryonic mice and human organoids.
• To identify specific molecular pathways involved in VPA teratogenicity.

Main Methods:

• Utilized embryonic mouse models and human organoid systems to simulate VPA exposure.
• Analyzed neuroepithelial (NE) cells for defects in neurogenesis and the induction of cellular senescence.
• Conducted genetic and functional studies to identify key mediators of VPA's effects, focusing on p19Arf.

Main Results:

• VPA exposure induced significant cellular senescence in NE cells of malformed embryonic tissues.
• Defective neurogenesis was observed in VPA-affected developing tissues.
• p19Arf was identified as a critical mediator for VPA-induced senescence and microcephaly, but not exencephaly or spinal defects.

Conclusions:

• Misregulated cellular senescence in NE cells is a significant contributor to VPA-induced developmental defects.
• p19Arf plays a specific role in mediating microcephaly following VPA exposure.
• These findings elucidate a novel mechanism of VPA teratogenicity, highlighting senescence as a key factor.